Procter & Gamble (NYSE:PG) Announces FY 2027 Earnings Guidance

Procter & Gamble (NYSE:PG) updated its FY 2027 earnings guidance on Friday. The company provided earnings per share (EPS) guidance of 6.890-7.110 for the period, compared to the consensus EPS estimate of 6.980. The company issued revenue guidance of $86.0 billion-$87.7 billion, compared to the consensus revenue estimate of $88.8 billion.

Analyst Ratings Changes

A number of research firms have recently weighed in on PG. Argus lowered Procter & Gamble from a “buy” rating to a “hold” rating in a research report on Friday, August 7th. Weiss Ratings reiterated a “hold (c)” rating on shares of Procter & Gamble in a report on Monday, September 21st. Barclays boosted their target price on Procter & Gamble from $146.00 to $152.00 and gave the stock an “equal weight” rating in a research note on Tuesday, July 21st. BMO Capital Markets boosted their target price on Procter & Gamble from $169.00 to $170.00 and gave the stock an “outperform” rating in a research note on Monday, June 29th. Finally, Morgan Stanley upped their price target on Procter & Gamble from $166.00 to $185.00 and gave the stock an “overweight” rating in a report on Friday. Fourteen research analysts have rated the stock with a Buy rating and ten have issued a Hold rating to the stock. According to data from MarketBeat.com, the company has an average rating of “Moderate Buy” and an average target price of $164.25.

Procter & Gamble Price Performance

Shares of PG opened at $163.22 on Friday. Procter & Gamble has a twelve month low of $137.62 and a twelve month high of $167.25. The firm’s fifty day simple moving average is $148.08 and its 200-day simple moving average is $146.99. The firm has a market capitalization of $379.11 billion, a price-to-earnings ratio of 24.65, a PEG ratio of 3.90 and a beta of 0.39. The company has a current ratio of 0.68, a quick ratio of 0.47 and a debt-to-equity ratio of 0.43.

Procter & Gamble (NYSE:PG) last released its quarterly earnings data on Thursday, October 22nd. The company reported $2.00 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.89 by $0.11. The business had revenue of $23.28 billion during the quarter, compared to analysts’ expectations of $22.80 billion. Procter & Gamble had a net margin of 18.44% and a return on equity of 31.36%. The company’s revenue for the quarter was up 4.0% on a year-over-year basis. During the same period in the previous year, the company earned $1.99 EPS. Equities analysts forecast that Procter & Gamble will post 6.98 EPS for the current fiscal year.

Procter & Gamble Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Monday, November 16th. Shareholders of record on Friday, October 23rd will be paid a $1.0885 dividend. The ex-dividend date is Friday, October 23rd. This represents a $4.35 dividend on an annualized basis and a yield of 2.7%. Procter & Gamble’s dividend payout ratio (DPR) is currently 65.71%.

Insider Activity at Procter & Gamble

In other news, CFO Andre Schulten sold 3,914 shares of the stock in a transaction dated Monday, October 5th. The stock was sold at an average price of $145.34, for a total value of $568,860.76. Following the transaction, the chief financial officer owned 65,618 shares in the company, valued at approximately $9,536,920.12. This represents a 5.63% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, CEO Paul Gama sold 2,225 shares of the firm’s stock in a transaction dated Monday, October 5th. The stock was sold at an average price of $145.34, for a total value of $323,381.50. Following the sale, the chief executive officer directly owned 51,124 shares in the company, valued at $7,430,362.16. This trade represents a 4.17% decrease in their position. The disclosure for this sale is available in the SEC filing. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Insiders sold 15,135 shares of company stock worth $2,189,970 over the last three months. Company insiders own 0.23% of the company’s stock.

Key Procter & Gamble News

Here are the key news stories impacting Procter & Gamble this week:

• Positive Sentiment: Quarterly results exceeded expectations. Fiscal Q1 2027 adjusted earnings were $2.00 per share, above the $1.89 consensus, while revenue increased 4% year over year to $23.28 billion, surpassing estimates of roughly $22.80 billion. Procter & Gamble earnings beat as sales rise 4%
• Positive Sentiment: Underlying growth was broad and volume-driven. Organic sales rose 4%, with volume contributing 2.4 percentage points. Laundry and home-care products were among the key contributors, while favorable product mix and productivity savings supported the earnings beat. Procter & Gamble: 3 Key Takeaways for Long-Term Investors
• Positive Sentiment: Management raised its fiscal 2027 all-in sales-growth outlook. The updated forecast reflects the acquisition of Thorne and reinforces investor confidence in the company’s ability to sustain growth. The earnings beat and defensive appeal also attracted buyers as broader large-cap markets weakened, helping PG reach a new 52-week high. Procter & Gamble Boosts FY27 All-in-sales Growth Outlook
• Neutral Sentiment: Procter & Gamble’s long record of dividend increases and low-beta, defensive business model remain attractive to income-focused investors, particularly amid elevated interest rates and economic uncertainty.
• Negative Sentiment: Higher commodity, energy and transportation costs remain a major risk. Management expects these pressures to persist through fiscal 2027 and indicated they could reduce annual profit by approximately $1.4 billion, potentially limiting margin expansion despite solid sales growth. P&G flags bigger hit to annual profit from higher commodity costs

About Procter & Gamble

Procter & Gamble Company (NYSE: PG) is a global consumer products company that develops, manufactures and markets branded products used in households and personal care. Its portfolio includes personal health and grooming products, beauty and skin care items, baby, feminine and family care products, fabric and home care products, and oral care products.

The company’s well-known brands include Pampers, Tide, Gillette, Crest, Oral-B, Head & Shoulders, Pantene, Olay, Old Spice, Dawn, Febreze and Mr.